Pinealon (EDR): Tripeptide Bioregulator Research Guide
Key Takeaways
- Pinealon is the tripeptide Glu-Asp-Arg (EDR), molecular weight 418.41 g/mol.
- It belongs to the short-peptide bioregulator class described by Khavinson and colleagues.
- The evidence base is largely preclinical and concentrated in one research group; independent replication is limited.
- Supplied for in-vitro laboratory research only. No dosing information and no human-use claims.
What is Pinealon?
The Proposed Mechanism
How to Weigh the Evidence
Laboratory Handling
Sourcing in the UK
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.
Frequently Asked Questions
What is Pinealon?
Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg, abbreviated EDR, and a molecular weight of 418.41 g/mol. It is studied as a short-peptide bioregulator. It is supplied as lyophilised powder for in-vitro laboratory research only.
How strong is the evidence for Pinealon?
Published work is largely preclinical and comes predominantly from one research group, with limited independent replication. Treat mechanistic proposals as hypotheses, not settled findings.
Where can I buy Pinealon in the UK?
UK Peptide Lab lists Pinealon 10mg as a research compound with a batch-specific certificate of analysis on the product page and same-day dispatch on orders placed before 3pm UK time. Research use only.